alexa Retinopathy Of Prematurity In Romania
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd Global Pediatric Ophthalmology Congress
June 05-06, 2017 Milan, Italy

Cristina Nitulescu
National Institute for Mother and Child Health, Romania
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570-C1-060
Abstract
Statement of the Problem: Retinopathy of prematurity (ROP) is the leading cause of childhood blindness in the world, but ROP detected and treated early is one of the most cost-effective preventions in all of medicine. Purpose: Analysis of challenges and gaps in ROP National Program in Romania. Methodology & Theoretical Orientation: In Romania the treatment of threshold ROP is based on the international classifying criteria for ROP (International Classification of Retinopathy of Prematurity) and on the results of the Early Treatment for Retinopathy of Prematurity Study – ETROP. There are few ROP cases presented with different treatment approaches for “threshold stage”- laser therapy, intra-ocular injection with Bevacizumab (Avastin), vitreoretinal surgery, alone or combined the evolution after treatment, as well as the reasons for unfavorable result in some cases. Findings: The disease completely regressed after treatment for all the babies screened and treated in time. All the babies who progressed to retinal detachment were referred too late for screening. The standard of neonatal care is critical with respect to the risk of ROP. Conclusion & Significance: The most important step in treating ROP is a good screening program. Laser therapy is the “gold” standard treatment for threshold ROP. Intra-ocular injection with Avastin is a therapeutic option for aggressive cases and for sick infants. We need a pediatric vitreoretinal surgery unit in Romania. In Romania, there is need more ophthalmologists specialized for ROP screening. The lack of screeners is opening doors to telemedicine, to ensure that every child at risk receives effective screening and treatment. The results of the screening program depend on a large measure on a good collaboration with neonatologists, pediatricians and parents.
Biography

Cristina Nitulescu has been involved in the Romanian National Retinopathy of Prematurity (ROP) Program since 2012, and from the beginning she realized that the premature babies’ destiny can be changed with a better care and a good screening program. She organized the first National ROP Symposium in 2015 for neonatologists, nurses and ophthalmologists, supported by the International Agency for Prevention of Blindness (IAPB) and the Romanian Society of Ophthalmology, to improve the children’s care and the results of ROP screening and treatment. She coordinates a new project, supported by IAPB, to mentor four ROP Excellence Regional Centers across the country, to provide support for a better collaboration at regional level and for the effective implementation of the ROP guidelines. It is mandatory that the health providers to be aware about ROP prevention, the mainstay of health care through the world.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords